Huntington hastalığına bağlı psikotik bozukluk ve tedaviye dirençli obsesif kompulsif bozukluk

Nurhan Fıstıkcı; Ömer Saatcioğlu; Evrim Erten; Görkem Yılmaz; Çağrı Çalcı; Ali Keyvan

Huntington hastalığına bağlı psikotik bozukluk ve tedaviye dirençli obsesif kompulsif bozukluk

Year 2013, Volume: 26 Issue: 2, 105 - 107, 01.10.2015

Nurhan Fıstıkcı Ömer Saatcioğlu Evrim Erten Görkem Yılmaz Çağrı Çalcı Ali Keyvan

Abstract

Huntington hastalığına bağlı gelişen psikiyatrik sorunların başında psikotik belirtiler, homisid ve özkıyım gelmektedir. Bu olguda, Huntington hastalığına bağlı psikotik bozukluk ve eşlik eden tedaviye dirençli obsesif kompulsif bozukluk tanısı olan bir hasta sunulmuştur.

Keywords

Huntington hastalığı, Obsesif kompulsif bozukluk, Psikoz

References

1. Paulsen JS. Understanding Behavior in Huntington’s Disesase. New York: Huntington’s Disease Society of America, 1999.
2. Van Dujin E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington’s disease gene carriers. J Neuropsychiatry Clin Neurosci 2007;19:441-8. doi: 10.1176/appi.neuropsych.19.4.441
3. Sadock BJ. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. I. cilt. Çeviri: Aydın H, Bozkurt A. Ankara: Güneş Kitapevi, 2007:414- 18.
4. Fiedorowicz JG, Mills JA, Ruggle A, Langbehn D, Paulsen JS. Suicidal behavior in prodromal Huntington Disease. Neurodegener Dis 2011; 8:483-90. doi: 10.1159/000327754
5. Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS. Huntington’s Study Group. Comorbidities of obsessive and compulsive symptoms in Huntington’s disease. J Nerv Ment Dis 2010;198:334-8. doi: 10.1097/NMD.0b013e3181da852a
6. Grabski B, Siwek M, Dudek D, Jaeschke R, Banaszkiewicz K. Schizophrenia-like psychotic symptoms in a patient with confirmed Huntington’s disease: a case report. Psychiatr Pol 2012; 46:665-75.
7. Chuo YP, Hou PH, Chan CH, Lin CC, Liao YC. Juvenile Huntington’s disease presenting as difficult-to-treat seizure and the first episode of psychosis. Gen Hosp Psychiatry 2012;34:436e9-11.doi: 10.1016/j. genhosppsych.2012.02.008
8. van Duijn E, Kingma EM, Timman R, et al. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington’s disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 2008; 69:1804-10.
9. Rickards H, De Souza J, van Walsem M, et al. Factor analysis of behavioural symptoms in Huntington’s disease. J Neurol Neurosurg Psychiatry 2011;82:411-12. doi: 10.1136/jnnp.2009.181149.
10. Gelegen V, Tamam L. Schizo-obsessive disorder. Current Approaches in Psychiatry 2013; 5: 204-19. doi:10.5455/cap.20130513.
11. Günal DÜ, Meliha Güleryüz M, Aktan S. Trinucleotide repeat length and clinical progression in Huntington’s disease. Marmara Med J 2000; 13:19-21.
12. Oulis P, Mourikis I, Konstantakopoulos G, Papageorgiou SG, Kouzoupis AV. Aripiprazole in the treatment of olanzapineresistant psychotic and motor symptoms of Huntington’s disease. J Neuropsychiatry Clin Neurosci 2010; 22: 352c e4- e5. doi: 10.1176/ appi.neuropsych.22.3.352-c.e4.
13. Frank S, Jankovic J. Advances in the pharmacological management of Huntington’s disease. Drugs 2010; 70:561-71.doi: 10.2165/11534430- 000000000-00000.
14. Johnston TG. Risperidone long-acting injection and Huntington’s disease: case series with significant psychiatric and behavioural symptoms. Int Clin Psychopharmacol 2011; 26:114-9.doi: 10.1097/ YIC.0b013e3283407775.

-

Year 2013, Volume: 26 Issue: 2, 105 - 107, 01.10.2015

Nurhan Fıstıkcı Ömer Saatcioğlu Evrim Erten Görkem Yılmaz Çağrı Çalcı Ali Keyvan

Abstract

Leading psychiatric problems due to Huntington’s disease are psychotic symptoms, homicide, and suicide. In this case, a patient with psychotic disorder due to Huntington’s disease and comorbid treatment-resistant obsessive-compulsive disorder is presented

Keywords

Huntington’s disease, Obsessive compulsive disorder, Psychosis

References

1. Paulsen JS. Understanding Behavior in Huntington’s Disesase. New York: Huntington’s Disease Society of America, 1999.
2. Van Dujin E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington’s disease gene carriers. J Neuropsychiatry Clin Neurosci 2007;19:441-8. doi: 10.1176/appi.neuropsych.19.4.441
3. Sadock BJ. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. I. cilt. Çeviri: Aydın H, Bozkurt A. Ankara: Güneş Kitapevi, 2007:414- 18.
4. Fiedorowicz JG, Mills JA, Ruggle A, Langbehn D, Paulsen JS. Suicidal behavior in prodromal Huntington Disease. Neurodegener Dis 2011; 8:483-90. doi: 10.1159/000327754
5. Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS. Huntington’s Study Group. Comorbidities of obsessive and compulsive symptoms in Huntington’s disease. J Nerv Ment Dis 2010;198:334-8. doi: 10.1097/NMD.0b013e3181da852a
6. Grabski B, Siwek M, Dudek D, Jaeschke R, Banaszkiewicz K. Schizophrenia-like psychotic symptoms in a patient with confirmed Huntington’s disease: a case report. Psychiatr Pol 2012; 46:665-75.
7. Chuo YP, Hou PH, Chan CH, Lin CC, Liao YC. Juvenile Huntington’s disease presenting as difficult-to-treat seizure and the first episode of psychosis. Gen Hosp Psychiatry 2012;34:436e9-11.doi: 10.1016/j. genhosppsych.2012.02.008
8. van Duijn E, Kingma EM, Timman R, et al. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington’s disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 2008; 69:1804-10.
9. Rickards H, De Souza J, van Walsem M, et al. Factor analysis of behavioural symptoms in Huntington’s disease. J Neurol Neurosurg Psychiatry 2011;82:411-12. doi: 10.1136/jnnp.2009.181149.
10. Gelegen V, Tamam L. Schizo-obsessive disorder. Current Approaches in Psychiatry 2013; 5: 204-19. doi:10.5455/cap.20130513.
11. Günal DÜ, Meliha Güleryüz M, Aktan S. Trinucleotide repeat length and clinical progression in Huntington’s disease. Marmara Med J 2000; 13:19-21.
12. Oulis P, Mourikis I, Konstantakopoulos G, Papageorgiou SG, Kouzoupis AV. Aripiprazole in the treatment of olanzapineresistant psychotic and motor symptoms of Huntington’s disease. J Neuropsychiatry Clin Neurosci 2010; 22: 352c e4- e5. doi: 10.1176/ appi.neuropsych.22.3.352-c.e4.
13. Frank S, Jankovic J. Advances in the pharmacological management of Huntington’s disease. Drugs 2010; 70:561-71.doi: 10.2165/11534430- 000000000-00000.
14. Johnston TG. Risperidone long-acting injection and Huntington’s disease: case series with significant psychiatric and behavioural symptoms. Int Clin Psychopharmacol 2011; 26:114-9.doi: 10.1097/ YIC.0b013e3283407775.

There are 14 citations in total.

Details

Primary Language	Turkish
Journal Section	Case Reports
Authors	Nurhan Fıstıkcı This is me Ömer Saatcioğlu This is me Evrim Erten This is me Görkem Yılmaz This is me Çağrı Çalcı This is me Ali Keyvan This is me
Publication Date	October 1, 2015
Published in Issue	Year 2013 Volume: 26 Issue: 2

Cite

APA	Fıstıkcı, N., Saatcioğlu, Ö., Erten, E., Yılmaz, G., et al. (2015). Huntington hastalığına bağlı psikotik bozukluk ve tedaviye dirençli obsesif kompulsif bozukluk. Marmara Medical Journal, 26(2), 105-107.
AMA	Fıstıkcı N, Saatcioğlu Ö, Erten E, Yılmaz G, Çalcı Ç, Keyvan A. Huntington hastalığına bağlı psikotik bozukluk ve tedaviye dirençli obsesif kompulsif bozukluk. Marmara Med J. October 2015;26(2):105-107.
Chicago	Fıstıkcı, Nurhan, Ömer Saatcioğlu, Evrim Erten, Görkem Yılmaz, Çağrı Çalcı, and Ali Keyvan. “Huntington hastalığına bağlı Psikotik Bozukluk Ve Tedaviye dirençli Obsesif Kompulsif Bozukluk”. Marmara Medical Journal 26, no. 2 (October 2015): 105-7.
EndNote	Fıstıkcı N, Saatcioğlu Ö, Erten E, Yılmaz G, Çalcı Ç, Keyvan A (October 1, 2015) Huntington hastalığına bağlı psikotik bozukluk ve tedaviye dirençli obsesif kompulsif bozukluk. Marmara Medical Journal 26 2 105–107.
IEEE	N. Fıstıkcı, Ö. Saatcioğlu, E. Erten, G. Yılmaz, Ç. Çalcı, and A. Keyvan, “Huntington hastalığına bağlı psikotik bozukluk ve tedaviye dirençli obsesif kompulsif bozukluk”, Marmara Med J, vol. 26, no. 2, pp. 105–107, 2015.
ISNAD	Fıstıkcı, Nurhan et al. “Huntington hastalığına bağlı Psikotik Bozukluk Ve Tedaviye dirençli Obsesif Kompulsif Bozukluk”. Marmara Medical Journal 26/2 (October 2015), 105-107.
JAMA	Fıstıkcı N, Saatcioğlu Ö, Erten E, Yılmaz G, Çalcı Ç, Keyvan A. Huntington hastalığına bağlı psikotik bozukluk ve tedaviye dirençli obsesif kompulsif bozukluk. Marmara Med J. 2015;26:105–107.
MLA	Fıstıkcı, Nurhan et al. “Huntington hastalığına bağlı Psikotik Bozukluk Ve Tedaviye dirençli Obsesif Kompulsif Bozukluk”. Marmara Medical Journal, vol. 26, no. 2, 2015, pp. 105-7.
Vancouver	Fıstıkcı N, Saatcioğlu Ö, Erten E, Yılmaz G, Çalcı Ç, Keyvan A. Huntington hastalığına bağlı psikotik bozukluk ve tedaviye dirençli obsesif kompulsif bozukluk. Marmara Med J. 2015;26(2):105-7.